Where to buy BPC-157 (Body Protection Compound-157) in the UK: the sellers with a verifiable COA
The newest verifiable BPC-157 certificate on any UK seller's website is on Zenic Labs (zeniclabs.co.uk), analysed 3 Sep 2026 (task #226528 on Janoshik's site); 20 verified sellers hold one covering BPC-157, listed newest first below.
A record of paperwork, not a recommendation: The Peptide Watch sells nothing, takes no money from sellers and links to none of them.
Who has the newest report · Why the date matters · What purity means · What BPC-157 is · Regulators · Every report
Who holds the newest BPC-157 report (20 verified UK sellers)
Newest report first. Every report was opened on Janoshik's own website and names the seller as the client. The date is the analysis date printed on the report. The verify link opens the laboratory, never the shop. Audit findings, not recommendations.
| Seller | Newest BPC-157 report | Age of that report | Purity on it | |
|---|---|---|---|---|
| Zenic Labs | 3 Sep 2026 | 1 month, 7 days | 99.892% | verify |
| Peptide Central UK | 13 Aug 2026 | 1 month, 27 days | 99.826% | verify |
| Lab77Peptides | 3 Aug 2026 | 2 months, 7 days | 98.329% | verify |
| UKMAXX | 27 Jul 2026 | 2 months, 13 days | 99.746% | verify |
| Thoroughbredlabs | 3 Jul 2026 | 3 months, 7 days | 97.845% | verify |
| Camo Chem | 25 Jun 2026 | 3 months, 15 days | 99.469% | verify |
| Biohacklondon | 19 Jun 2026 | 3 months, 21 days | 99.635% | verify |
| Kingston Peptides | 4 Jun 2026 | 4 months, 6 days | 99.126% | verify |
| Intel Peptides | 25 May 2026 | 4 months, 15 days | 99.915% | verify |
| Biohackpeptides | 21 May 2026 | 4 months, 19 days | 99.762% | verify |
| Peptideprime | 14 May 2026 | 4 months, 26 days | 99.788% | verify |
| Phoenixbiolabs | 13 May 2026 | 4 months, 27 days | 99.304% | verify |
| Peptidesresearch | 13 May 2026 | 4 months, 27 days | 99.817% | verify |
| Peptifyuk | 11 May 2026 | 4 months, 29 days | 99.763% | verify |
| Kensingtonlabs | 5 May 2026 | 5 months, 5 days | 99.487% | verify |
| Imperialpeptides | 24 Apr 2026 | 5 months, 16 days | 99.923% | verify |
| Bodylab Store | 21 Apr 2026 | 5 months, 19 days | 99.414% | verify |
| Peptide Coding UK | 17 Apr 2026 | 5 months, 23 days | 99.814% | verify |
| Xlpeptides | 16 Mar 2026 | 6 months, 24 days | 99.802% | verify |
| Clinicore | 16 Jan 2026 | 8 months, 24 days | 99.754% | verify |
Every BPC-157 purity report we have read (24), one row per report
The 24 verifiable BPC-157 certificates we have read, newest first
Each row was opened on Janoshik's own site by a real page load and transcribed. The client column is the name the laboratory printed; a certificate counts as a seller's own only when that name is the seller. The report date is the analysis date printed on the report where we have read it, otherwise the date the laboratory received the sample. The verify link opens the laboratory, never the shop. Audit findings, not recommendations.
| Seller | Task | Client on the report | Report date | Result | Batch | |
|---|---|---|---|---|---|---|
| Zenic Labs | #226528 | Zenic Labs | 3 Sep 2026 | BPC-157 · 5.71 mg · 99.892% | ZEN-2608-001 | verify |
| Thoroughbredlabs | #225278 | Thoroughbred Labs | 1 Sep 2026 | Arg-BPC-157 (BPC-157 content) · 490.83 mcg | 0526BP | verify |
| Peptide Central UK | #217543 | Peptide Central UK | 13 Aug 2026 | BPC-157 · 11.81 mg · 99.826% | 100237 | verify |
| Lab77Peptides | #208427 | Lab77peptides.co.uk | 3 Aug 2026 | BPC-157 · 10.68 mg · 98.329% | L77BPC268 | verify |
| UKMAXX | #208699 | UKMAXX | 27 Jul 2026 | BPC-157 · 4.84 mg · 99.746% | BPC-2026-05-A | verify |
| Thoroughbredlabs | #202784 | Thoroughbred Labs | 3 Jul 2026 | BPC-157 · 10.79 mg · 97.845% | TBLBP261 | verify |
| Camo Chem | #193497 | Camo Chem UK | 25 Jun 2026 | BPC-157 · 5.39 mg · 99.469% | 500EU-06-2026 | verify |
| Biohacklondon | #168578 | BioHack London Ltd | 19 Jun 2026 | BPC-157 · 10.93 mg · 99.635% | 2026-06 | verify |
| Kingston Peptides | #162963 | Kingston Peptides | 4 Jun 2026 | BPC-157 · 11.02 mg · 99.126% | BPC-101A | verify |
| Intel Peptides | #157748 | Intel Peptides | 25 May 2026 | BPC-157 · 11.07 mg · 99.915% | 26001 | verify |
| Reta24 | #165340 | (a private individual's name) | 25 May 2026 | BPC-157 · 10.08 mg · 99.897% | Unknown | verify |
| Biohackpeptides | #162903 | BiohackPeptides.co.uk | 21 May 2026 | BPC-157 · 11.34 mg · 99.762% | BHP26EBC10 | verify |
| Peptideprime | #151114 | Peptide Prime | 14 May 2026 | BPC-157 · 10.88 mg · 99.788% | BPC10-0526 | verify |
| Peptidesresearch | #152764 | Blue Peak Peptides | 13 May 2026 | BPC-157 · 10.82 mg · 99.817% | BPCCUX-02 | verify |
| Phoenixbiolabs | #147246 | www.phoenixbiolabs.net | 13 May 2026 | BPC-157 · 10.75 mg · 99.304% | Batch-0179 used in vials + pen(s) | verify |
| Peptifyuk | #149059 | Peptify UK | 11 May 2026 | BPC-157 · 11.55 mg · 99.763% | 2026/04 | verify |
| Kensingtonlabs | #121946 | Kensington Labs | 5 May 2026 | BPC-157 · 4.22 mg · 99.487% | BPC-275QI | verify |
| Imperialpeptides | #150394 | Imperial Peptides UK | www.imperialpeptides.co.uk | 24 Apr 2026 | BPC-157 · 10.64 mg · 99.923% | BPC10-03/28 | verify |
| Bodylab Store | #150821 | Bodylab Store | 21 Apr 2026 | BPC-157 · 11.63 mg · 99.414% | BLS0330-001 | verify |
| Peptide Coding UK | #135625 | Peptide Coding Ltd | 17 Apr 2026 | BPC-157 · 10.74 mg · 99.814% | JY26 | verify |
| Xlpeptides | #121800 | XL Peptides | 16 Mar 2026 | BPC-157 · 5.48 mg · 99.802% | 263BPC | verify |
| Clinicore | #99957 | clinicore | 16 Jan 2026 | BPC-157 · 21.49 mg · 99.754% | bp20-101 | verify |
| Xlpeptides | #88414 | XL Peptides | 13 Nov 2025 | BPC-157 · 5.55 mg · 99.412% | 007003 | verify |
| Xlpeptides | #56762 | XL Peptides | 28 Jan 2025 | BPC-157 · 5.09 mg · 99.334% | 007001 | verify |
Why the date on a certificate matters
What a purity figure means
The purity on a Janoshik report is the share of the main peak in an HPLC chromatogram. 99.5% means that 99.5% of what the detector saw was one substance and 0.5% was something else. It is not the amount in the vial: that is the separate quantity line, in milligrams. It does not by itself prove which substance the peak is: that is identity, confirmed by mass spectrometry. And it says nothing about sterility, endotoxins or heavy metals, which are separate tests.
A purity figure printed on a shop page with no report behind it is a claim, not a measurement. Between two reports, the difference that matters is rarely 99.2% against 99.8%; it is whether the report exists at all, names the seller as the client, covers this compound on its own, and is recent.
What BPC-157 is, and what it is sold as
BPC-157 is a synthetic 15-amino-acid peptide derived from a protein found in gastric juice, widely studied in preclinical research on tissue repair. It is the single most-sold research peptide in the UK, which also makes it the most faked and the most borrowed-certificate prone.
| Development status | Never in clinical development. The 4 registered studies are small phase 1 and 2 studies by clinics and start-ups, none by a pharmaceutical developer; never approved anywhere. |
|---|---|
| Originator | Predrag Sikiric and colleagues, University of Zagreb; first described in 1993. Rights: Diagen d.o.o. (Slovenia), of which Sikiric is CEO, holds patents on a stabilised form it calls BPC 157 Stable and advertises the rights for sale. |
| Registered clinical trials | 4 on ClinicalTrials.gov |
It is almost entirely one laboratory's animal work. 172 of the 221 papers indexed on PubMed carry the same researcher as an author, Predrag Sikiric of Zagreb, and 117 are indexed as rat or mouse studies. The claims you will see repeated on shop pages, faster tendon and muscle healing, gut protection, vessel repair, come from that rodent literature.
No clinical trial has been published. PubMed indexes 0 papers on BPC-157 as a clinical trial or randomised controlled trial. The 26 human papers that are not reviews are small pilot studies and case series with no control group, for example a knee-pain injection series and an intravenous-infusion safety pilot, both in a single alternative-medicine journal.
What that means for a buyer. Nobody has shown BPC-157 works in people for anything, and nobody has established a safe human dose. The US FDA's compounding page records that BPC-157 "may pose risk for immunogenicity for certain routes of administration and may have complexities with regard to peptide-related impurities", and that the agency "lacks sufficient information to know whether the drug would cause harm when administered to humans". Impurities are exactly what a verifiable certificate tests for, which is why this site exists.
The published record in numbers, and the sources
| Papers on PubMed | 221 |
|---|---|
| Indexed as rat or mouse studies | 117 |
| Indexed as clinical trials | 0 |
| Published since 2020 | 100 |
Counts are from PubMed on 15 September 2026 using the queries recorded in our evidence file. A description of the published record, not medical advice and not an argument for or against use.
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (HSS J, 2025, PMID 40756949)
- Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing (Curr Rev Musculoskelet Med, 2025, PMID 40789979)
- Stable Gastric Pentadecapeptide BPC 157 and Wound Healing (Front Pharmacol, 2021, PMID 34267654)
- Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain (Altern Ther Health Med, 2021, PMID 34324435)
- Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study (Altern Ther Health Med, 2025, PMID 40131143)
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration (J Appl Physiol, 2011, PMID 21030672)
- Diagen d.o.o., BPC 157 discovery and development
- Diagen d.o.o., BPC 157 Stable patent rights for sale
- STAT News, 1 June 2026, on Sikiric and the BPC-157 patents
What regulators say about BPC-157
In the UK. Not a licensed medicine in the UK. Sold as a research chemical.
US FDA, Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. BPC-157 entry: "may pose risk for immunogenicity for certain routes of administration and may have complexities with regard to peptide-related impurities and active pharmaceutical ingredient (API) characterization. FDA has identified no, or only limited, safety-related information for the proposed routes of administration. Therefore, the agency lacks sufficient information to know whether the drug would cause harm when administered to humans." Page current as of 22 April 2026, where BPC-157 sits under bulk drug substances nominated but withdrawn (it was placed in category 2 in 2023; HHS announced a review of that group of peptides on 27 February 2026). Source.
What the 24 BPC-157 certificates show
We have read 24 Janoshik reports covering BPC-157, published by 21 UK sellers. Each was opened on Janoshik's own website. 23 of the 24 name the seller itself as the client; the rest name a supplier or a different shop. 20 of the 24 are dated within the last six months and 1 is more than a year old. The newest is dated 3 Sep 2026 and the oldest 28 Jan 2025.
23 of the reports give a purity figure for BPC-157. The figures run from 97.845% to 99.923%, and 21 of the 23 are at 99% or above. 1 more gives the amount recovered and no purity figure for it, which is usual where the vial holds a blend. A purity figure describes the sample the laboratory received, not every vial from that batch.
Read directly from the newest reports: Zenic Labs: task #226528, analysed 3 Sep 2026, 5.71 mg recovered at 99.892%, client Zenic Labs; Peptide Central UK: task #217543, analysed 13 Aug 2026, 11.81 mg recovered at 99.826%, client Peptide Central UK; Lab77Peptides: task #208427, sample received 3 Aug 2026, 10.68 mg recovered at 98.329%, client Lab77peptides.co.uk.
A certificate is a batch document. The lines that matter are the compound (it must say BPC-157, not only a batch code), the client (the shop, not its supplier) and the analysis date. A new batch is untested until a new report appears.
BPC-157 in the UK at a glance
| Active UK sellers listing BPC-157 | 149 |
|---|---|
| Of which publish a verifiable own-name certificate | 24 |
| Of which name no laboratory at all | 45 |
Counted from the vendor ledger at build time. The A-Z directory lists every seller and what each publishes instead.
Questions people ask
Which UK sellers publish a verifiable Janoshik certificate naming BPC-157?
As of 10 October 2026, 20: Zenic Labs, Thoroughbredlabs, Peptide Central UK, Lab77Peptides, UKMAXX, Camo Chem, Biohacklondon, Kingston Peptides, Intel Peptides, Biohackpeptides, Peptideprime, Phoenixbiolabs, Peptidesresearch, Peptifyuk, Kensingtonlabs, Imperialpeptides, Bodylab Store, Peptide Coding UK, Xlpeptides, Clinicore. Each has a report on Janoshik's own website that names the seller as the client and lists BPC-157. That is a statement about paperwork, not a recommendation; The Peptide Watch does not recommend anywhere to buy BPC-157.
How recent is the newest BPC-157 certificate from a UK seller?
The newest we have read is Janoshik task #226528, analysed 3 Sep 2026. It is published by Zenic Labs and names it as the client. A certificate covers one batch, so an old one says little about stock on sale today.
How do I check that a certificate for BPC-157 is genuine?
Four things: an independent laboratory is named; the client field names the seller you are buying from, not a supplier; the compound line says BPC-157; and the report's task number and key open the same report on the laboratory's own website (verify.janoshik.com). A branded PDF with no laboratory name and no verification code fails on the first check, however professional it looks. The free COA Checker on this site runs the checks for you.
Is BPC-157 a licensed medicine in the UK?
Not a licensed medicine in the UK. Sold as a research chemical. The 4 registered studies are small phase 1 and 2 studies by clinics and start-ups, none by a pharmaceutical developer; never approved anywhere. The Peptide Watch does not give legal or medical advice.
Why does The Peptide Watch not say where to buy BPC-157?
Because the site records paperwork, not recommendations. A verifiable certificate proves that a sample of one batch was tested. It does not prove the vial you receive matches it, and it says nothing about whether anyone should use BPC-157. Listing which sellers publish a certificate you can check, and which publish nothing, is as far as the evidence goes.
The Peptide Watch's position on BPC-157
Not a licensed medicine in the UK. Sold as a research chemical. The Peptide Watch reads the certificates UK sellers publish and does not recommend anywhere to buy BPC-157. Sellers on this page are listed by the date of their newest BPC-157 certificate and by nothing else. If you can verify a seller's testing, you can at least judge its evidence; if you cannot, you are taking the seller's word for what is in the vial. See how UK testing compares across every seller in the market statistics.
An honest note: a verifiable certificate proves a sample of a batch was tested, not that the specific vial you receive matches it, see what this can and can't tell you. The Peptide Watch sells no BPC-157 and links to no shop; this is research-use-only information, not medical or dosing advice.
All peptides · Other compounds: TB-500 · GHK-Cu · Ipamorelin · CJC-1295 · MOTS-c · Epithalon · Selank · Semax · Tesamorelin · Melanotan 2 · KPV · PT-141 · SS-31 · DSIP · NAD+ · Melanotan 1 · AOD-9604 · 5-Amino-1MQ · Glutathione · Kisspeptin · Thymosin Alpha-1 · GHRP-6 · HGH Fragment 176-191 · IGF-1 LR3 · FOXO4-DRI · Oxytocin · SLU-PP-332 · MK-677 · GLOW and KLOW blends · Sermorelin · GHRP-2 · Hexarelin · ARA-290 · AHK-Cu